Polianta Ltd’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-13,200
Closed -$828K 73
2022
Q1
$828K Buy
+13,200
New +$828K 0.54% 69